12. Endogenous Peptides and Their Receptors as Drug Discovery Targets for the Treatment of Metabolic Disease

  1. Prof. Dr. Miguel Castanho and
  2. Prof. Dr. Nuno C. Santos
  1. Mary Ann Pelleymounter1,
  2. Yuren Wang1 and
  3. Ning Lee2

Published Online: 17 OCT 2011

DOI: 10.1002/9783527636730.ch12

Peptide Drug Discovery and Development: Translational Research in Academia and Industry

Peptide Drug Discovery and Development: Translational Research in Academia and Industry

How to Cite

Pelleymounter, M. A., Wang, Y. and Lee, N. (2011) Endogenous Peptides and Their Receptors as Drug Discovery Targets for the Treatment of Metabolic Disease, in Peptide Drug Discovery and Development: Translational Research in Academia and Industry (eds M. Castanho and N. C. Santos), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527636730.ch12

Editor Information

  1. University of Lisbon, Institute of Biochemistry, Av. Egas Moniz, 1649-028 Lisboa, Portugal

Author Information

  1. 1

    Bristol Myers Squibb, Department of Metabolic Diseases, NJ 08534 Hopewell, USA

  2. 2

    Bristol Myers Squibb, Department of Metabolic AQ4 Diseases, NJ 08534 Hopewell, USA

Publication History

  1. Published Online: 17 OCT 2011
  2. Published Print: 5 OCT 2011

ISBN Information

Print ISBN: 9783527328918

Online ISBN: 9783527636730

SEARCH

Keywords:

  • endogenous peptides;
  • metabolic disease;
  • obesity;
  • neuropeptide;
  • centrally secreted neuropeptide;
  • peripherally secreted neuropeptide

Summary

This chapter contains sections titled:

  • Centrally Secreted Neuropeptide Systems

  • Peripherally Secreted Neuropeptides

  • Summary